Home | Repositories | Statistics | About



Subject: Delphi method
Subject: Global health
Subject: NAFLD/NASH
Subject: Non-communicable disease (NCD)
Subject: Steatotic liver disease


Year: 2023


Type: Article



Title: A global research priority agenda to advance public health responses to fatty liver disease


Author: Lazarus, Jeffrey V
Author: Mark, Henry E
Author: Allen, Alina M
Author: Arab, Juan Pablo
Author: Carrieri, Patrizia
Author: Noureddin, Mazen
Author: Alazawi, William
Author: Alkhouri, Naim
Author: Alqahtani, Saleh A
Author: Arrese, Marco
Author: Bataller, Ramon
Author: Berg, Thomas
Author: Brennan, Paul N
Author: Burra, Patrizia
Author: Castro-Narro, Graciela E
Author: Cortez-Pinto, Helena
Author: Cusi, Kenneth
Author: Dedes, Nikos
Author: Duseja, Ajay
Author: Francque, Sven M
Author: Hagström, Hannes
Author: Huang, Terry T-K
Author: Wajcman, Dana Ivancovsky
Author: Kautz, Achim
Author: Kopka, Christopher J
Author: Krag, Aleksander
Author: Miller, Veronica
Author: Newsome, Philip N
Author: Rinella, Mary E
Author: Romero, Diana
Author: Sarin, Shiv Kumar
Author: Silva, Marcelo
Author: Spearman, C Wendy
Author: Tsochatzis, Emmanuel A
Author: Valenti, Luca
Author: Villota-Rivas, Marcela
Author: Zelber-Sagi, Shira
Author: Schattenberg, Jörn M
Author: Wong, Vincent Wai-Sun
Author: Younossi, Zobair M
Author: the Healthy Livers, Healthy Lives Collaborators
Author: Nikolova, Dafina



Abstract: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community.


Publisher:


Relation: Journal of hepatology



Identifier: oai:repository.ukim.mk:20.500.12188/27925
Identifier: http://hdl.handle.net/20.500.12188/27925
Identifier: 10.1016/j.jhep.2023.04.035
Identifier: 79
Identifier: 3



TitleDateViews
A global research priority agenda to advance public health responses to fatty liver disease202332